Delivering the IFNB1 into melanoma cells with its defective expression may increase these cells’ susceptibility to IFNB1, which exerts a dose-dependent anti-proliferative and apoptotic effect on melanoma cells. The gene discussed is IFNB1; the disease is melanoma.